This study is registered at http://www.umin.ac.jp/ctrj/ under C000000206.
You have full text access to this Open Access content
Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: A retrospective analysis of JALSG-APL97
Version of Record online: 4 AUG 2013
© 2013 Japanese Cancer Association
Volume 104, Issue 10, pages 1339–1345, October 2013
How to Cite
(Cancer Sci 2013; 104: 1339–1345
- Issue online: 3 OCT 2013
- Version of Record online: 4 AUG 2013
- Accepted manuscript online: 10 JUL 2013 01:58AM EST
- Manuscript Accepted: 1 JUL 2013
- Manuscript Revised: 25 JUN 2013
- Manuscript Received: 2 APR 2013
- Japanese Ministry of Education, Culture, Sport, Science, and Technology
- National Cancer Center Research and Development Fund
- Cancer Research from the Japanese Ministry of Health, Labor and Welfare
- 6Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene. Blood 1997; 90: 1321–5., , et al.
- 9Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. J Clin Oncol 2005; 23: 120–6., , et al.
- 15A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study. Blood 2007; 110: 59–66., , et al.
- 20Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Biol Blood Marrow Transplant 2009; 15: 1479–84., , et al.